MicheliA.,
BailiP.,
QuinnM.,
MugnoE.,
CapocacciaR.,
GrosclaudeP.
and the EUROCARE Working Group: Life expectancy and cancer
survival in the EUROCARE-3 cancer registry areas.Ann Oncol14: 28–40,
2003.
Decreto Legislativo 19 giugno 1999, n. 229.
“Norme per la razionalizzazione del Servizio sanitario nazionale, a
norma dell'articolo 1 della legge 30 novembre 1998, n. 419”.
Available at http://www.parlamento.it/leggi/deleghe/99229dl.htm
GrandeE.,
InghelmannR.,
FrancisciS.,
VerdecchiaA.,
MicheliA.,
BailiP.,
CapocacciaR.,
De AngelisR.:
Regional estimates of all cancer malignancies in
Italy.Tumori,93: 345–351,
2007.
14.
GrandeE.,
InghelmannR.,
FrancisciS.,
VerdecchiaA.,
MicheliA.,
BailiP.,
CapocacciaR.,
De AngelisR.:
Regional estimates of colorectal cancer burden in
Italy.Tumori,93: 352–359,
2007.
15.
InghelmannR.,
GrandeE.,
FrancisciS.,
VerdecchiaA.,
MicheliA.,
BailiP.,
CapocacciaR.,
De AngelisR.:
Regional estimates of lung cancer burden in
Italy.Tumori,93: 360–366,
2007.
16.
InghelmannR.,
GrandeE.,
FrancisciS.,
VerdecchiaA.,
MicheliA.,
BailiP.,
GattaG.,
CapocacciaR.,
ValdagniR.,
De AngelisR.:
Regional estimates of prostate cancer burden in
Italy.Tumori,93: 380–386,
2007.
17.
InghelmannR.,
GrandeE.,
FrancisciS.,
VerdecchiaA.,
MicheliA.,
BailiP.,
CapocacciaR.,
De AngelisR.:
Regional estimates of stomach cancer burden in
Italy.Tumori,93: 367–373,
2007.
18.
VerdecchiaA.,
De AngelisR.,
FrancisciS.,
GrandeE.:
Methodology for estimation of cancer incidence, survival and
prevalence in Italian regions.Tumori,93: 337–344,
2007.
19.
BailiP.,
De AngelisR.,
CasellaI.,
GrandeE.,
InghelmannR.,
FrancisciS.,
VerdecchiaA.,
CapocacciaR.,
MeneghiniE.,
MicheliA.:
Italian cancer burden by broad geographical
area.Tumori,93: 398–407,
2007.
20.
De
AngelisR.,
GrandeE.,
InghelmannR.,
FrancisciS.,
MicheliA.,
BailiP.,
MeneghiniE.,
CapocacciaR.,
VerdecchiaA.:
Cancer prevalence estimates in Italy from 1970 to
2010.Tumori,93: 392–397,
2007.
VerdecchiaA.,
MicheliA.,
GattaG.:
Survival of cancer patients in Italy. The Itacare
Study.Tumori,83(1), 1997.
23.
RossoS.,
CasellaC.,
CrocettiE.,
FerrettiS.,
GuzzinatiS
(Eds): Survival of cancer patients in Italy in the nineties:
figures from the Cancer Registries.Epidemiol Prev,25(suppl 3):
1–375, 2001.
24.
ColemanM.P.,
GattaG.,
VerdecchiaA.,
EsteveJ.,
SantM.,
StormH.,
AllemaniC.,
CiccolalloL.,
SantaquilaniM.,
BerrinoF.
EUROCARE Working Group: EUROCARE-3 summary: cancer survival in
Europe at the end of the 20th century.Ann Oncol,14 (Suppl 5):
128–149, 2003.
25.
AIRTum Working Group:
Italian Cancer Figures, Report 2007:
Survival.Epidemiol Prev, 31(1), Suppl 1,
2007.
26.
QuagliaA.,
CapocacciaR.,
MicheliA.,
CarraniE.,
VercelliM.:
A wide difference in cancer survival between middle aged and
elderly patients in Europe.Int J Cancer,120(10):
2196–2201, 2007.
27.
MeropolN.J.,
SchulmanK.A.:
Cost of cancer care: issues and implications.J Clin Oncol,25(2): 180–186,
2007.
28.
American Cancer
Society.Cancer Facts and Figures, 2007.
29.
WarnerK.E.:
The economics of tobacco: myths and
realities.Tob Control,9(1): 78–89,
2000.
30.
SoerjomataramI.,
de VriesE.,
PukkalaE.,
CoeberghJ.W.:
Excess of cancers in Europe: a study of eleven major cancers
amenable to lifestyle change.Int J Cancer,120(6): 1336–1343,
2007.
ZieglerR.G.,
HooverR.N.,
PikeM.C.,
HildesheimA.,
NomuraA.M.,
WestD.W.,
Wu-WilliamsA.H.,
KolonelL.N.,
Horn-RossP.L.,
RosenthalJ.F.,
HyerM.B.:
Migration patterns and breast cancer risk in Asian-American
women.J Natl Cancer Inst,85(22): 1819–1827,
1993.
33.
ThomasD.B.,
KaragasM.R.:
Cancer in first and second generation
Americans.Cancer Res,47(21): 5771–5776,
1987.
34.
PetoR.,
DarbyS.,
DeoH.,
SilcocksP.,
WhitleyE.,
DollR.:
Smoking, smoking cessation, and lung cancer in the UK since
1950: combination of national statistics with two casecontrol
studies.BMJ,321(7257):
323–329, 2000.
35.
TuomilehtoJ.,
LindstromJ.,
ErikssonJ.G.,
ValleT.T.,
HamalainenH.,
Ilanne-ParikkaP.,
Keinanen-KiukaanniemiS.,
LaaksoM.,
LouherantaA.,
RastasM.,
SalminenV.,
UusitupaM.;
Finnish Diabetes Prevention Study Group: Prevention of type 2
diabetes mellitus by changes in lifestyle among subjects with impaired
glucose tolerance.N Engl J Med, 344(18):
1343–1350, 2001.
36.
XuW.,
QiuC.,
WinbladB.,
FratiglioniL.:
The effect of borderline diabetes on the risk of dementia and
Alzheimer's disease.Diabetes,56(1): 211–216,
2007.
37.
KorpelainenR.,
KorpelainenJ.,
HeikkinenJ.,
VaananenK.,
Keinanen-KiukaanniemiS.:
Lifelong risk factors for osteoporosis and fractures in
elderly women with low body mass index. A population-based
study.Bone,39(2): 385–391,
2006.
38.
EnglundU.,
LittbrandH.,
SondellA.,
PetterssonU.,
BuchtG.:
A 1-year combined weight-bearing training program is
beneficial for bone mineral density and neuromuscular function in older
women.Osteoporos Int,16(9): 1117–1123,
2005.
39.
BerrinoF.,
PasanisiP.,
BellatiC.,
VenturelliE.,
KroghV.,
MastroianniA.,
BerselliE.,
MutiP.,
SecretoG.:
Serum testosterone levels and breast cancer
recurrence.Int J Cancer,113(3): 499–502,
2005.
40.
FontanaL.,
KleinS.:
Aging, adiposity, and calorie restriction.JAMA,297(9): 986–994,
2007.
41.
BerrinoF.,
BellatiC.,
SecretoG.,
CameriniE.,
PalaV.,
PanicoS.,
AllegroG.,
KaaksR.:
Reducing bioavailable sex hormones through a comprehensive
change in diet: the diet and androgens (DIANA) randomized
trial.Cancer Epidemiol Biomarkers Prev,10(1): 25–33,
2001.
42.
KaaksR.,
BellatiC.,
VenturelliE.,
RinaldiS.,
SecretoG.,
BiessyC.,
PalaV.,
SieriS.,
BerrinoF.:
Effects of dietary intervention on IGF-I and IGF-binding
proteins, and related alterations in sex steroid metabolism: the Diet and
Androgens (DIANA) Randomised Trial.Eur J Clin Nutr,57(9): 1079–1088,
2003.
43.
FontanaL.,
MeyerT.E.,
KleinS.,
HolloszyJ.O.:
Long-term calorie restriction is highly effective in reducing
the risk for atherosclerosis in humans.Proc Natl Acad Sci USA,101(17):
6659–6663, 2004.
44.
PottiA.,
DressmanH.K.,
BildA.,
RiedelR.F.,
ChanG.,
SayerR.,
CragunJ.,
CottrillH.,
KelleyM.J.,
PetersenR.,
HarpoleD.,
MarksJ.,
BerchuckA.,
GinsburgG.S.,
FebboP.,
LancasterJ.,
NevinsJ.R.:
Genomic signatures to guide the use of
chemotherapeutics.Nat Med,12(11): 1294–1300,
2006.
45.
BoshoffC.:
New targets for cancer therapy: minireview reprints
collection.Br J Cancer, 96: R1,
2007.
46.
AntonescuC.R.,
BesmerP.,
GuoT.,
ArkunK.,
HomG.,
KoryotowskiB.,
LevershaM.A.,
JeffreyP.D.,
DesantisD.,
SingerS.,
BrennanM.F.,
MakiR.G.,
DeMatteoR.P.:
Acquired resistance to imatinib in gastrointestinal stromal
tumor occurs through secondary gene mutation.Clin Cancer Res,11(11): 4182–4190,
2005.
47.
WeisbergE.,
ManleyP.W.,
Cowan-JacobS.W.,
HochhausA.,
GriffinJ.D.:
Second generation inhibitors of BCR-ABL for the treatment of
imatinib-resistant chronic myeloid leukaemia.Nat Rev Cancer,7(5): 345–356,
2007.